Playback speed
10 seconds
Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High Risk for Vascular Outcomes - ACCELERATE Trial
825 views
July 26, 2016
Dr. Steve Nissen discusses the results and clinical implications of the ACCELERATE Trail, presented at ...
read more ↘ ACC.16, a trial designed to study a class of drugs called CETP inhibitors, intended to decrease risk of cardiovascular disease.
↖ read less
read more ↘ ACC.16, a trial designed to study a class of drugs called CETP inhibitors, intended to decrease risk of cardiovascular disease.
↖ read less
Login to view comments.
Click here to Login